Tian Zhou

Guiyang, 550004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Ovarian escape in premenopausal breast cancer: Challenges and strategies for optimizing hormone suppression.

Ovarian escape in premenopausal breast cancer: Challenges and strategies for optimizing hormone suppression.

Journal: Cancer treatment reviews

Published: April 03, 2025

ACTN1 promotes cell invasion, migration, and EMT in thyroid cancer and is associated with immune infiltration.

ACTN1 promotes cell invasion, migration, and EMT in thyroid cancer and is associated with immune infiltration.

Journal: Scientific reports

Published: August 22, 2024

A pan-cancer analysis of the prognosis and immune infiltration of eEF1A2 and its potential function in thyroid carcinoma.

A pan-cancer analysis of the prognosis and immune infiltration of eEF1A2 and its potential function in thyroid carcinoma.

Journal: Heliyon

Published: September 16, 2023

Transcription factor FOXP4 inversely governs tumor suppressor genes and contributes to thyroid cancer progression.

Transcription factor FOXP4 inversely governs tumor suppressor genes and contributes to thyroid cancer progression.

Journal: Heliyon

Published: April 28, 2023

The essential role of forkhead box P4 (FOXP4) in thyroid cancer: a study related to The Cancer Genome Atlas and experimental data.

The essential role of forkhead box P4 (FOXP4) in thyroid cancer: a study related to The Cancer Genome Atlas and experimental data.

Journal: Endocrine connections

Published: January 15, 2023

FOXP4-AS1 Inhibits Papillary Thyroid Carcinoma Proliferation and Migration Through the AKT Signaling Pathway.

FOXP4-AS1 Inhibits Papillary Thyroid Carcinoma Proliferation and Migration Through the AKT Signaling Pathway.

Journal: Frontiers in oncology

Published: March 21, 2022

Progress in application of long non-coding RNA in the diagnosis and treatment of thyroid cancer.

Progress in application of long non-coding RNA in the diagnosis and treatment of thyroid cancer.

Journal: Asian journal of surgery

Published: March 01, 2022

Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.

Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.

Journal: Cancer medicine

Published: June 03, 2019

GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple-negative breast cancer via upregulation of Smad7.

GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple-negative breast cancer via upregulation of Smad7.

Journal: Aging

Published: November 13, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026